Researchers conducted a retrospective cohort study at 39 U.S. pediatric hospitals using data from the Pediatric Health Information Systems administrative database, according to the University of Minnesota’s Center for Infectious Disease Research and Policy in Minneapolis.
Researchers found pediatric S. aureus hospitalizations decreased 36 percent from 26.3 per 1,000 admissions in 2009 to 16.8 infections per 1,000 admissions in 2016. Methicillin-resistant S. aureus decreased by 52 percent and methicillin-susceptible S. aureus decreased by 17 percent over the study period.
Additionally, there were similar decreases for days of therapy using anti-MRSA antibiotics.
More articles on healthcare quality:
How Stanford chemists are modifying antibiotics to fight MRSA
CDC taps Virginia Tech researchers to study antibiotic resistance in water
How emerging tech will change training for next-generation physicians
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
